| Ogsiveo 150 mg film‑coated tablets EU/1/25/1932/004 |
Nirogacestat hydrobromide |
Springworks Therapeutics Ireland Limited |
— |
| Ogsiveo 50 mg film‑coated tablets EU/1/25/1932/001-002 |
Nirogacestat hydrobromide |
Springworks Therapeutics Ireland Limited |
— |
| Olanzapine 10mg Orodispersible Tablets PA2315/229/002 |
Olanzapine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Olanzapine 15mg Orodispersible Tablets PA2315/229/003 |
Olanzapine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Olanzapine 20mg Orodispersible Tablets PA2315/229/004 |
Olanzapine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Olanzapine 5 mg Orodispersible Tablets PA2315/229/001 |
Olanzapine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Olanzapine Accord 10 mg film-coated tablets PA2315/112/004 |
Olanzapine |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olanzapine Accord 15 mg film-coated tablets PA2315/112/005 |
Olanzapine |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olanzapine Accord 2.5 mg film-coated tablets PA2315/112/001 |
Olanzapine |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olanzapine Accord 5 mg film-coated tablets PA2315/112/002 |
Olanzapine |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olanzapine Accord 7.5 mg film-coated tablets PA2315/112/003 |
Olanzapine form 1 |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olbas Inhaler nasal stick PA22702/002/003 |
Cajuput oil, Levomenthol, Eucalyptus oil, Peppermint oil |
LanesHealth (Ireland) Limited |
Marketed |
| Olbas Oil PA22702/002/001 |
Cajuput oil, Clove oil, Eucalyptus oil, Juniper oil, Mint oil, partly dementholised |
LanesHealth (Ireland) Limited |
Marketed |
| Olmesartan Medoxomil 10 mg film-coated tablets PA2315/113/001 |
Olmesartan medoxomil |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olmesartan Medoxomil 20 mg film-coated tablets PA2315/113/002 |
Olmesartan medoxomil |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olmesartan Medoxomil 40 mg film-coated tablets PA2315/113/003 |
Olmesartan medoxomil |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olmesartan medoxomil/Amlodipine 20 mg/5 mg film-coated tablets PA2315/074/001 |
Olmesartan medoxomil, Amlodipine |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olmesartan medoxomil/Amlodipine 40 mg/10 mg film-coated tablets PA2315/074/003 |
Olmesartan medoxomil, Amlodipine |
Accord Healthcare Ireland Ltd. |
Marketed |
| Olmesartan medoxomil/Amlodipine 40 mg/5 mg film-coated tablets PA2315/074/002 |
Olmesartan medoxomil, Amlodipine |
Accord Healthcare Ireland Ltd. |
Marketed |
| Omeprazole 10 mg hard gastro-resistant capsules PA2315/129/001 |
Omeprazole |
Accord Healthcare Ireland Ltd. |
Marketed |
| Omeprazole 20 mg hard gastro-resistant capsules PA2315/129/002 |
Omeprazole |
Accord Healthcare Ireland Ltd. |
Marketed |
| Omeprazole 40 mg hard gastro-resistant capsules PA2315/129/003 |
Omeprazole |
Accord Healthcare Ireland Ltd. |
Marketed |
| Omidria 10 mg/ml + 3 mg/ml concentration for solution for intraocular irrigation EU/1/15/1018/001 |
Phenylephrine hydrochloride, Ketorolac trometamol |
Rayner Surgical (Ireland) Limited |
— |
| Ondansetron 2 mg/ml Solution for Injection or Infusion PA2315/168/001 |
Ondansetron |
Accord Healthcare Ireland Ltd. |
Marketed |
| Opsaren 10 mg Film-coated Tablets PA22865/018/001 |
Macitentan |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Optrex Clear Eyes Eye Drops Solution Hamamelis Water 12.5% v/v Naphazoline Hydrochloride 0.01% w/v PA0979/079/001 |
Hamamelis water, Naphazoline hydrochloride |
Reckitt Benckiser Ireland Limited |
Not marketed |
| Oraldene 0.1% w/v Gargle/Mouthwash PA23490/009/001 |
Hexetidine |
JNTL Consumer Health I (Ireland) Limited |
Marketed |
| Oraldene Icemint 0.1% w/v Gargle/Mouthwash Hexetidine PA23490/009/002 |
Hexetidine |
JNTL Consumer Health I (Ireland) Limited |
Not marketed |
| Ordspono 2 mg Concentrate for solution for infusion EU/1/24/1843/001 |
Odronextamab |
Regeneron Ireland Designated Activity Company |
— |
| Ordspono 320 mg Concentrate for solution for infusion EU/1/24/1843/003 |
Odronextamab |
Regeneron Ireland Designated Activity Company |
— |
| Ordspono 80 mg Concentrate for solution for infusion EU/1/24/1843/002 |
Odronextamab |
Regeneron Ireland Designated Activity Company |
— |
| Orkambi 100 mg/125 mg film-coated tablets EU/1/15/1059/005 |
Lumacaftor, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orkambi 100 mg/125 mg granules in sachet EU/1/15/1059/006 |
Lumacaftor, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orkambi 150 mg/188 mg granules in sachet EU/1/15/1059/007 |
Ivacaftor, Lumacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orkambi 200 mg/125 mg film-coated tablets EU/1/15/1059/001 |
Lumacaftor, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orkambi 75 mg/94 mg granules in sachet EU/1/15/1059/008 |
Lumacaftor, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orladeyo 150 mg hard capsules EU/1/21/1544/001 |
Berotralstat hydrochloride, Berotralstat |
BioCryst Ireland Ltd |
— |
| Orlistat Accord 120 mg hard capsules PA2315/263/001 |
Orlistat |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Otrivine Adult 0.1% w/v Nasal Drops, Solution PA0678/120/001 |
Xylometazoline hydrochloride |
Haleon Ireland Limited |
Marketed |
| Otrivine Adult Menthol 0.1% w/v Nasal Spray, Solution PA0678/120/004 |
Xylometazoline hydrochloride |
Haleon Ireland Limited |
Not marketed |
| Otrivine Congestion Relief 0.1% w/v Nasal Spray, Solution PA0678/120/002 |
Xylometazoline hydrochloride |
Haleon Ireland Limited |
Not marketed |
| Otrivine Congestion Relief Menthol 0.1% w/v Nasal Spray PA0678/120/005 |
Xylometazoline hydrochloride |
Haleon Ireland Limited |
Marketed |
| Otrivine Extra Dual Relief 0.5mg/ml + 0.6mg/ml nasal spray, solution PA0678/131/001 |
Xylometazoline hydrochloride, Ipratropium bromide |
Haleon Ireland Limited |
Marketed |
| Otrivine Sinusitis Relief 0.1% w/v Nasal Spray, Solution PA0678/120/003 |
Xylometazoline hydrochloride |
Haleon Ireland Limited |
Marketed |
| Ovaleap 300 IU/0.5 mL solution for injection EU/1/13/871/001-003 |
Follitropin alfa |
Theramex Ireland Limited |
— |
| Ovranette 150 micrograms/30 micrograms coated tablets PA0822/094/001 |
Ethinyloestradiol, Levonorgestrel |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Oxaliplatin 5 mg/ml Concentrate for Solution for Infusion PA2315/114/001 |
Oxaliplatin |
Accord Healthcare Ireland Ltd. |
Marketed |
| Oxybutynin hydrochloride 2.5 mg tablets PA2315/038/001 |
Oxybutynin hydrochloride |
Accord Healthcare Ireland Ltd. |
Marketed |
| Oxybutynin Hydrochloride 5mg Tablets PA2315/038/002 |
Oxybutynin hydrochloride |
Accord Healthcare Ireland Ltd. |
Marketed |
| Pabal 100 micrograms/ml, solution for injection PA1009/021/001 |
Carbetocin |
Ferring Ireland Ltd |
Not marketed |